Literature DB >> 3244639

Thiol reduction of 3'-azidothymidine to 3'-aminothymidine: kinetics and biomedical implications.

A L Handlon1, N J Oppenheimer.   

Abstract

The ability of thiols to reduce 3'-azidothymidine (AZT) to 3'-aminothymidine has been investigated. Incubation with glutathione, dithiothreitol (DTT), or mercaptoethanol at pH 7.2 and 37 degrees C leads to quantitative reduction of the azido moiety to an amine. The reaction is first order in AZT and first order in reducing agent (mono- or dithiol). The second-order rate constants are 2.77 x 10(-3), 6.55 x 10(-5), and 6.35 x 10(-6) M-1 sec-1 for the dithiothreitol, glutathione, and mercaptoethanol reductions, respectively. The thiol reduction of alkyl azide to amine under mild conditions is a synthetic method particularly suitable for water-soluble azido compounds that are sensitive to catalytic hydrogenation. The potential for the mono- or dithiol-mediated reduction of alkyl azides under biological conditions must be considered when conducting studies of azido drugs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244639     DOI: 10.1023/a:1015926720740

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Reduction of aryl azides by thiols: implications for the use of photoaffinity reagents.

Authors:  J V Staros; H Bayley; D N Standring; J R Knowles
Journal:  Biochem Biophys Res Commun       Date:  1978-02-14       Impact factor: 3.575

2.  Aminonucleosides and their derivatives. IV. Synthesis of the 3'-amino-3'-deoxynucleoside 5'-phosphates.

Authors:  A V Azhayev; A M Ozols; A S Bushnev; N B Dyatkina; S V Kochetkova; L S Victorova; M K Kukhanova; A A Krayevsky; B P Gottikh
Journal:  Nucleic Acids Res       Date:  1979-02       Impact factor: 16.971

3.  Oligomerization of activated derivatives of 3'-amino-3'-deoxyguanosine on poly(C) and poly(dC) templates.

Authors:  W S Zielinski; L E Orgel
Journal:  Nucleic Acids Res       Date:  1985-04-11       Impact factor: 16.971

4.  3'-azido-3'-deoxythymidine. An unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion.

Authors:  T P Zimmerman; W B Mahony; K L Prus
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

5.  3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.

Authors:  H Mitsuya; K J Weinhold; P A Furman; M H St Clair; S N Lehrman; R C Gallo; D Bolognesi; D W Barry; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

6.  Preparative and analytical high-performance liquid chromatographic methods in the synthesis and analysis of decomposition of nitrosourea nucleosides.

Authors:  W F Brubaker; W H Prusoff
Journal:  J Chromatogr       Date:  1985-04-10

7.  Synthesis and biological activity of several amino analogues of thymidine.

Authors:  T S Lin; W H Prusoff
Journal:  J Med Chem       Date:  1978-01       Impact factor: 7.446

8.  Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs.

Authors:  Y C Cheng; G E Dutschman; K F Bastow; M G Sarngadharan; R Y Ting
Journal:  J Biol Chem       Date:  1987-02-15       Impact factor: 5.157

9.  Synthesis and antiviral activity of various 3'-azido, 3'-amino, 2',3'-unsaturated, and 2',3'-dideoxy analogues of pyrimidine deoxyribonucleosides against retroviruses.

Authors:  T S Lin; M S Chen; C McLaren; Y S Gao; I Ghazzouli; W H Prusoff
Journal:  J Med Chem       Date:  1987-02       Impact factor: 7.446

  9 in total
  8 in total

1.  Investigation of reactions postulated to occur during inhibition of ribonucleotide reductases by 2'-azido-2'-deoxynucleotides.

Authors:  Thao P Dang; Adam J Sobczak; Alexander M Mebel; Chryssostomos Chatgilialoglu; Stanislaw F Wnuk
Journal:  Tetrahedron       Date:  2012-04-21       Impact factor: 2.457

2.  Synthesis and biological evaluation of orally active prodrugs and analogs of para-aminosalicylic acid (PAS).

Authors:  Pooja V Hegde; Michael D Howe; Matthew D Zimmerman; Helena I M Boshoff; Sachin Sharma; Brianna Remache; Ziyi Jia; Yan Pan; Anthony D Baughn; Veronique Dartois; Courtney C Aldrich
Journal:  Eur J Med Chem       Date:  2022-02-19       Impact factor: 6.514

3.  Selective Engineering of Linkage-Specific α2,6-N-Linked Sialoproteins Using Sydnone-Modified Sialic Acid Bioorthogonal Reporters.

Authors:  Zoeisha S Chinoy; Clément Bodineau; Camille Favre; Kelley W Moremen; Raúl V Durán; Frédéric Friscourt
Journal:  Angew Chem Int Ed Engl       Date:  2019-02-19       Impact factor: 15.336

4.  Lack of evidence for in vivo transformation of zidovudine triphosphate to stavudine triphosphate in human immunodeficiency virus-infected patients.

Authors:  Margarita Meléndez; Raúl Blanco; Wilfredo Delgado; Rosario García; Jorge Santana; Hermes García; Osvaldo Rosario; José F Rodríguez
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

5.  Bioorthogonal chemistry: fishing for selectivity in a sea of functionality.

Authors:  Ellen M Sletten; Carolyn R Bertozzi
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

6.  ω-Conotoxin GVIA mimetics that bind and inhibit neuronal Ca(v)2.2 ion channels.

Authors:  Charlotte Elisabet Tranberg; Aijun Yang; Irina Vetter; Jeffrey R McArthur; Jonathan B Baell; Richard J Lewis; Kellie L Tuck; Peter J Duggan
Journal:  Mar Drugs       Date:  2012-10-22       Impact factor: 6.085

7.  Synthesis of phosphoramidate-linked DNA by a modified DNA polymerase.

Authors:  Victor S Lelyveld; Wen Zhang; Jack W Szostak
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-18       Impact factor: 11.205

8.  Bifunctional Reagents for Formylglycine Conjugation: Pitfalls and Breakthroughs.

Authors:  Nils Janson; Tobias Krüger; Lennard Karsten; Mareile Boschanski; Thomas Dierks; Kristian M Müller; Norbert Sewald
Journal:  Chembiochem       Date:  2020-09-18       Impact factor: 3.164

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.